[Administration of monoamine oxidase inhibitors in experimental atherosclerosis].
D000818:Animals; D001161:Arteriosclerosis / Q000139:chemically induced / Q000188:drug therapy* / Q000517:prevention & control; D001669:Biochemical Phenomena; D001671:Biochemistry; D002784:Cholesterol / Q000097:blood; D004195:Disease Models, Animal; D004372:Ducks; D050356:Lipid Metabolism; D008055:Lipids / Q000097:blood; D008996:Monoamine Oxidase Inhibitors / Q000627:therapeutic use*; D009526:Nialamide / Q000627:therapeutic use*; D010743:Phospholipids / Q000097:blood
D008055:Lipids; D008996:Monoamine Oxidase Inhibitors; D010743:Phospholipids; D002784:Cholesterol; D009526:Nialamide
Anwendung einiger Monoaminooxydase-Inhibitoren bei der experimentellen Atherosklerose.